Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Fendrich

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Digestive Surgery|July 2, 2011
Neuroendocrine pancreatic tumors are risk factors for pancreatic fistula after pancreatic surgeryVolker Fendrich, Marianne K Merz, Jens Waldmann, et al.
European Journal of Endocrinology|January 30, 2009
Unique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasiaVolker Fendrich, Jens Waldmann, Georg Feldmann, et al.
Annals of Surgery|January 18, 2011
Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumorsVolker Fendrich, Johannes Rehm, Jens Waldmann, et al.
Cancers|November 12, 2013
Epithelial-mesenchymal transition is a critical step in tumorgenesis of pancreatic neuroendocrine tumorsVolker Fendrich, Katja Maschuw, Jens Waldmann, et al.
Endocrine|April 29, 2009
Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomasJens Waldmann, Peter Langer, Nils Habbe, et al.
Familial Cancer|January 6, 2011
German national case collection for familial pancreatic cancer (FaPaCa): ten years experienceRalph Schneider, Emily P Slater, Mercede Sina, et al.
Nature Structural & Molecular Biology|June 1, 2010
DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RASMatthias Lauth, Asa Bergström, Takashi Shimokawa, et al.
Langenbeck'S Archives of Surgery|August 31, 2013
Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model of pancreatic cancerLars Plassmeier, Richard Knoop, Jens Waldmann, et al.
Biomedicines|September 28, 2024
Increased Myocardial MAO-A, Atrogin-1, and IL-1β Expression in Transgenic Mice with Pancreatic Carcinoma-Benefit of MAO-A Inhibition for Cardiac CachexiaKira Stelter, Annalena Alabssi, Gabriel Alejandro Bonaterra, et al.
Neoplasia (New York, N.Y.)|June 24, 2014
Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancerRichard F Knoop, Moritz Sparn, Jens Waldmann, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Digestive Surgery|July 2, 2011
Neuroendocrine pancreatic tumors are risk factors for pancreatic fistula after pancreatic surgeryVolker Fendrich, Marianne K Merz, Jens Waldmann, et al.
European Journal of Endocrinology|January 30, 2009
Unique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasiaVolker Fendrich, Jens Waldmann, Georg Feldmann, et al.
Annals of Surgery|January 18, 2011
Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumorsVolker Fendrich, Johannes Rehm, Jens Waldmann, et al.
Cancers|November 12, 2013
Epithelial-mesenchymal transition is a critical step in tumorgenesis of pancreatic neuroendocrine tumorsVolker Fendrich, Katja Maschuw, Jens Waldmann, et al.
Endocrine|April 29, 2009
Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomasJens Waldmann, Peter Langer, Nils Habbe, et al.
Familial Cancer|January 6, 2011
German national case collection for familial pancreatic cancer (FaPaCa): ten years experienceRalph Schneider, Emily P Slater, Mercede Sina, et al.
Nature Structural & Molecular Biology|June 1, 2010
DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RASMatthias Lauth, Asa Bergström, Takashi Shimokawa, et al.
Langenbeck'S Archives of Surgery|August 31, 2013
Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model of pancreatic cancerLars Plassmeier, Richard Knoop, Jens Waldmann, et al.
Biomedicines|September 28, 2024
Increased Myocardial MAO-A, Atrogin-1, and IL-1β Expression in Transgenic Mice with Pancreatic Carcinoma-Benefit of MAO-A Inhibition for Cardiac CachexiaKira Stelter, Annalena Alabssi, Gabriel Alejandro Bonaterra, et al.
Neoplasia (New York, N.Y.)|June 24, 2014
Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancerRichard F Knoop, Moritz Sparn, Jens Waldmann, et al.
Pageof 11